Impala Platinum Spon Stock Earnings Reports

Key points for investors: Implats benefited from a ~30% increase in rand PGM spot prices (around ZAR 32,200/6E), driven by physical tightness, shifting trade flows and a discount to gold. The group strengthened its balance sheet during the low-price period: gross cash ZAR 11.6bn, net cash ZAR 8.1bn and liquidity (~ZAR 20bn headroom including undrawn facilities). The Board declared a ZAR 1.65/share dividend (~ZAR 1.5bn), representing ~60% of adjusted free cash flow, signalling a bias to increased shareholder returns while keeping the balance sheet strong. FY26 refined production guidance is 3.4–3.6Moz (6E); Impala Bafokeng guidance raised to ~540koz (driven by Styldrift ramp), Impala Canada guidance lowered to 170–190koz due to planned cessation. The group delivered free cash flow of ZAR 2.4bn for the year and reduced all-in unit costs ~3% to ZAR 25,700. Reported safety metrics improved (LTI frequency -11%, recordable injuries -15%) but the company recorded 8 fatalities and remains focused on further culture change. Major operational issue: persistent processing/refinery constraints and inventory build-up (reported excess inventory ~420,000oz), caused by a combination of furnace refractory erosion (driven by a higher UG2 corrosive feed blend), timing of concentrate dispatches (e.g., Mimosa export issues), and utility disruptions (heavy rains, wet coal, hydrogen supply). Management is rebuilding and redesigning furnaces (new refractory designs, raised tap-holes, increased cooling) and expects phased releases of excess metal over coming years. Capital guidance is ZAR 8–9bn (mostly sustaining capex); the published profile excludes discretionary life-of-mine extension/expansion projects, which could be added if higher prices persist. The company highlights its integrated, geographically diversified position and excess processing capacity flexibility as strategic advantages. Overall message: Implats is cash-generative with a stronger balance sheet and a clear intention to prioritise shareholder returns while addressing near-term processing risks and pursuing selective life-extension opportunities if market conditions justify.